SABITA THAPA: Open Payments
NPI 1770953374 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$387 in 15 payments from 11 companies in 2025. Trend: 2023 $2,805 · 2024 $3,743 · 2025 $387
Food & beverage: $387
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 3 | $89 |
| Astellas Pharma US Inc | 3 | $70 |
| Janssen Scientific Affairs, LLC | 1 | $42 |
| Adaptive Biotechnologies Corporation | 1 | $33 |
| Celgene Corporation | 1 | $28 |
| Legend Biotech USA Inc. | 1 | $26 |
| ABBVIE INC. | 1 | $24 |
| UCB, Inc. | 1 | $23 |
| SANOFI-AVENTIS U.S. LLC | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $17 |
Products named: Vyloy, KISQALI, CARVYKTI, clonoSEQ, REBLOZYL, EPKINLY, Bimzelx, SCEMBLIX.
Industry payments across TX — which companies pay providers there.
